BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

696 related articles for article (PubMed ID: 15652808)

  • 1. Proteomics analysis of human cerebrospinal fluid.
    Yuan X; Desiderio DM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 815(1-2):179-89. PubMed ID: 15652808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometer (LC MALDI TOF/TOF) platform.
    Pan S; Rush J; Peskind ER; Galasko D; Chung K; Quinn J; Jankovic J; Leverenz JB; Zabetian C; Pan C; Wang Y; Oh JH; Gao J; Zhang J; Montine T; Zhang J
    J Proteome Res; 2008 Feb; 7(2):720-30. PubMed ID: 18186601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of proteins in human cerebrospinal fluid using liquid-phase isoelectric focusing as a prefractionation step followed by two-dimensional gel electrophoresis and matrix-assisted laser desorption/ionisation mass spectrometry.
    Davidsson P; Folkesson S; Christiansson M; Lindbjer M; Dellheden B; Blennow K; Westman-Brinkmalm A
    Rapid Commun Mass Spectrom; 2002; 16(22):2083-8. PubMed ID: 12415540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of proteome of human cerebrospinal fluid.
    Xu J; Chen J; Peskind ER; Jin J; Eng J; Pan C; Montine TJ; Goodlett DR; Zhang J
    Int Rev Neurobiol; 2006; 73():29-98. PubMed ID: 16737901
    [No Abstract]   [Full Text] [Related]  

  • 5. Proteomics analysis of prefractionated human lumbar cerebrospinal fluid.
    Yuan X; Desiderio DM
    Proteomics; 2005 Feb; 5(2):541-50. PubMed ID: 15627968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarker discovery for kidney diseases by mass spectrometry.
    Niwa T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):148-53. PubMed ID: 18024247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-Gel 18O labeling for improved identification of proteins from 2-DE Gel spots in comparative proteomic experiments.
    Broedel O; Krause E; Stephanowitz H; Schuemann M; Eravci M; Weist S; Brunkau C; Wittke J; Eravci S; Baumgartner A
    J Proteome Res; 2009 Jul; 8(7):3771-7. PubMed ID: 19425618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomics of cerebrospinal fluid: methods for sample processing.
    Hale JE; Gelfanova V; You JS; Knierman MD; Dean RA
    Methods Mol Biol; 2008; 425():53-66. PubMed ID: 18369886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiling of myelin proteins by 2D-gel electrophoresis and multidimensional liquid chromatography coupled to MALDI TOF-TOF mass spectrometry.
    Vanrobaeys F; Van Coster R; Dhondt G; Devreese B; Van Beeumen J
    J Proteome Res; 2005; 4(6):2283-93. PubMed ID: 16335977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of proteins from human cerebrospinal fluid, separated by two-dimensional polyacrylamide gel electrophoresis.
    Sickmann A; Dormeyer W; Wortelkamp S; Woitalla D; Kuhn W; Meyer HE
    Electrophoresis; 2000 Jul; 21(13):2721-8. PubMed ID: 10949151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteome studies of CSF in AD patients.
    Davidsson P; Sjögren M
    Mech Ageing Dev; 2006 Feb; 127(2):133-7. PubMed ID: 16293296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shotgun proteomics: tools for the analysis of complex biological systems.
    Wu CC; MacCoss MJ
    Curr Opin Mol Ther; 2002 Jun; 4(3):242-50. PubMed ID: 12139310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in sample preparation for classical and second generation proteomics.
    Cañas B; Piñeiro C; Calvo E; López-Ferrer D; Gallardo JM
    J Chromatogr A; 2007 Jun; 1153(1-2):235-58. PubMed ID: 17276441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic analysis of the cerebrospinal fluid of patients with schizophrenia.
    Jiang L; Lindpaintner K; Li HF; Gu NF; Langen H; He L; Fountoulakis M
    Amino Acids; 2003 Jul; 25(1):49-57. PubMed ID: 12836058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteome analysis of chick embryonic cerebrospinal fluid.
    Parada C; Gato A; Aparicio M; Bueno D
    Proteomics; 2006 Jan; 6(1):312-20. PubMed ID: 16287170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of alternative analytical techniques for the characterisation of the human serum proteome in HUPO Plasma Proteome Project.
    Li X; Gong Y; Wang Y; Wu S; Cai Y; He P; Lu Z; Ying W; Zhang Y; Jiao L; He H; Zhang Z; He F; Zhao X; Qian X
    Proteomics; 2005 Aug; 5(13):3423-41. PubMed ID: 16052619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomics and physiology of erythritol-producing strains.
    Park YC; Lee DY; Lee DH; Kim HJ; Ryu YW; Seo JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 815(1-2):251-60. PubMed ID: 15652814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of preparative and analytical two-dimensional electrophoresis for isolation and matrix-assisted laser desorption/ionization-time-of-flight mass spectrometric analysis of transthyretin in cerebrospinal fluid.
    Westman-Brinkmalm A; Davidsson P
    Anal Biochem; 2002 Feb; 301(2):161-7. PubMed ID: 11814286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A combined dataset of human cerebrospinal fluid proteins identified by multi-dimensional chromatography and tandem mass spectrometry.
    Pan S; Zhu D; Quinn JF; Peskind ER; Montine TJ; Lin B; Goodlett DR; Taylor G; Eng J; Zhang J
    Proteomics; 2007 Feb; 7(3):469-73. PubMed ID: 17211832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of differentially expressed proteins of gamma-ray irradiated rat intestinal epithelial IEC-6 cells by two-dimensional gel electrophoresis and matrix-assisted laser desorption/ionisation-time of flight mass spectrometry.
    Bo Z; Yongping S; Fengchao W; Guoping A; Yongjiang W
    Proteomics; 2005 Feb; 5(2):426-32. PubMed ID: 15700242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.